Human irak-2, a human interleukin-1 receptor associated...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/54 (2006.01) A61K 38/45 (2006.01) C12N 9/12 (2006.01) G01N 33/50 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2311610

The present invention relates to a novel IRAK-2 protein which is a member of the IL-1 signaling pathway. In particular, isolated nucleic acid molecules are provided encoding the human IRAK-2 protein. IRAK-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for detecting IRAK-2 related disorders and therapeutic methods for treating IRAK-2 related disorders.

La présente invention concerne une nouvelle protéine IRAK-2, membre de la voie de signalisation de l'IL-1. En particulier, l'invention concerne des molécules d'acide nucléique isolées codant la protéine IRAK-2 humaine. L'invention concerne également des polypeptides IRAK-2, ainsi que des vecteurs, des cellules hôtes et des méthodes de recombinaison permettant de les produire. L'invention concerne, en outre, des méthodes diagnostiques permettant de détecter des troubles liés à l'IRAK-2 et des méthodes thérapeutiques permettant de traiter des troubles liés à l'IRAK-2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Human irak-2, a human interleukin-1 receptor associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human irak-2, a human interleukin-1 receptor associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human irak-2, a human interleukin-1 receptor associated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2043958

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.